ArticleInfectious disease reports2024
Proprotein Convertase Subtilisin Kexin 9 Inhibitor in Severe Sepsis and Septic Shock Patients in a Phase II Prospective Cohort Study-Preliminary Results.
Ziv Rosman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.